Back
ESC Professional Premium Access

Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

Session: Public health and health economics
Topic: Health Economics
Speaker: Doctor R. Sandhu (Calgary, CA)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Roopinder Sandhu

University of Calgary, Calgary (Canada)
1 follower

5 more presentations in this session

Cardiovascular risk factor prevalence, treatment, and control among US adults by income, 2009-2023.

Speaker: Doctor L. Marinacci (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative validation of the AHA PREVENT equation with US and European cardiovascular risk equations among 892,000 adults

Speaker: Doctor J. Diao (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Should body mass index categories differ by ethnicity? All-cause mortality and incident cardiovascular disease in a multi-ethnic cohort of 400,000 adults

Speaker: Mr C. Li (Auckland, NZ)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of abnormal findings in health check-ups on medical care: findings from 15 years of health check-ups

Speaker: Doctor S. Kameda (Shimotsuke, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

External validation of the ISARIC-4C mortality risk prediction score in patients hospitalized with COVID-19: Retrospective analysis of the World Heart Federation (WHF) COVID-19 Global Study

Speaker: Doctor K. Singh (Gurgaon, IN)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Public health and health economics

Speakers: Doctor R. Sandhu, Doctor L. Marinacci, Doctor J. Diao, Mr C. Li, Doctor S. Kameda...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources